Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. - Wikidata - wikimedia - TriplyDB

Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level.

Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level.

http://www.wikidata.org/entity/Q33700218

about

Cognitive function is largely intact in methadone maintenance treatment patients.Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective.Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial.

P2860

Q38375656-6A3C5C1B-60F6-489D-931C-22C2AF1E0F89 Q47312712-853B2E64-36FA-4A6B-9FA3-ED6E82A7936D Q49496990-A159BA37-1DF9-40C9-922C-E4B98638777B

P2860

Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level.

http://www.wikidata.org/entity/Q33700218

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cognitive performance in metha ...... ng and maintenance dose level.

@ast

Cognitive performance in metha ...... ng and maintenance dose level.

@en

type

label

Cognitive performance in metha ...... ng and maintenance dose level.

@ast

Cognitive performance in metha ...... ng and maintenance dose level.

@en

prefLabel

Cognitive performance in metha ...... ng and maintenance dose level.

@ast

Cognitive performance in metha ...... ng and maintenance dose level.

@en

P1433

Q33700218-5EE9C6DE-CA3E-4584-9B76-A20ADE944E76

P1476

Q33700218-15774003-B585-42D5-97C0-2D5D9060A388

P2093

Q33700218-063059D4-2910-4175-907D-597EE5749211

Q33700218-40AB9906-4D31-401C-877C-6E85DF65308A

Q33700218-43A4428A-188E-4B91-94A2-17FBE8F312AA

Q33700218-4F79C09F-455E-4DD4-AD48-A5878DF1F43A

Q33700218-A0094A26-F5B1-4E6C-A0C1-80355609A470

Q33700218-A2CBE055-C41E-498A-B510-094AC026F9F1

Q33700218-A7E6ABE1-3870-411D-B6D0-37701BCBE730

Q33700218-DBC5CD0E-68D8-485C-B86B-7C418CBB7167

P2860

Q33700218-036B32D8-62D2-4795-A61E-D8F8A2C01444

Q33700218-088802C6-7C06-485F-8965-8D417F08B2F1

Q33700218-0FBA99E4-C177-41A2-AB1F-236794FAD0B8

Q33700218-1C842AF7-DF72-4CEB-87BF-0ED8006F92C3

Q33700218-1CFCCA19-FE98-4756-9EAC-DC984D9F1A2D

Q33700218-229EA679-53C8-4DBD-B0F9-AEF21F452C29

Q33700218-2F070544-3B1A-443F-AB24-59B1630356E4

Q33700218-2FC3BA12-54AB-4BA9-80D1-2AF8FEA53CA2

Q33700218-300A1F27-C325-4F64-9CA0-6B5104ACA4CF

Q33700218-31099892-99D0-4AB8-A1CD-D0740E8654C5

P304

Q33700218-FDF9151F-538A-4458-8A1F-97CBBE901F94

P31

Q33700218-DDDAED83-214D-44BC-A262-93BFB97E15FE

P356

Q33700218-F1933F15-189C-4917-B54C-67508F9ADD04

P433

Q33700218-13D33D79-99BB-478C-A89F-ED99AD156D3F

P478

Q33700218-BE0D6B0A-34FA-4F18-B758-621D3712C163

P50

Q33700218-8BC54C7C-26D2-4D77-A00D-71918FDB5C30

P577

Q33700218-4BA38F66-DB5D-4136-A404-1A8FC151DEF3

P5875

Q33700218-677C241E-E63C-41A8-A25D-45052DDA2B42

P698

Q33700218-788612A0-DC6B-4C1A-851A-F4EA8C6630C8

P932

Q33700218-03780832-ED03-4C33-9BD8-ED5E8D8BF11D

P356

P1433

Experimental and Clinical Psychopharmacology

P1476

Cognitive performance in metha ...... ng and maintenance dose level.

@en

P2093

Bethea A Kleykamp

http://www.w3.org/2001/XMLSchema#string

Eric C Strain

http://www.w3.org/2001/XMLSchema#string

George E Bigelow

http://www.w3.org/2001/XMLSchema#string

Jeannie-Marie Leoutsakos

http://www.w3.org/2001/XMLSchema#string

Marc L Copersino

http://www.w3.org/2001/XMLSchema#string

Maxine L Stitzer

http://www.w3.org/2001/XMLSchema#string

Miriam Z Mintzer

http://www.w3.org/2001/XMLSchema#string

Ryan G Vandrey

http://www.w3.org/2001/XMLSchema#string

P2860

Methadone maintenance at different dosages for opioid dependence

Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment

Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.

Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.

Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers.

Cognitive-motor performance of methadone-maintained patients.

Clinical pharmacology of buprenorphine: ceiling effects at high doses.

Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results.

Predictors of methadone treatment retention from a multi-site study: a survival analysis.

Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation.

P304

248-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1037/A0035712

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260251411

http://www.w3.org/2001/XMLSchema#string

P698

24548244

http://www.w3.org/2001/XMLSchema#string

P932

4041803

http://www.w3.org/2001/XMLSchema#string